Aminoglutethimide-induced hematologic toxicity: worldwide experience.

A. A. Messeih, Allan Lipton, Richard J. Santen, Harold H. Harvey, Alice E. Boucher, Rachael Z. Murray, Joseph Ragaz, A. U. Buzdar, Georg Nagel, I. Craig Henderson

PubMed · 1985 · 10 citations · 0 references

Concepts

Abstract

Marked leukopenia and/or thrombocytopenia occurred in 12 of 1333 patients treated with aminoglutethimide (0.9% incidence). Depression of blood cell counts was evident within 7 weeks of starting treatment. No delayed toxicity was encountered. Blood cell counts recovered promptly upon cessation of aminoglutethimide in all but one patient, who died from septicemia and marrow aplasia.